Increasing use of blood tests to detect prostate cancer is leading to overworked doctors. Researchers have now created an AI diagnostic tool that can help.

New study finds microplastics in 90% of prostate cancer tumors, with double the concentration in cancerous tissue compared to healthy tissue from patient samples.

The research lays a foundation for the possibility that aggressive prostate cancer can probably be detected through a few drops of semen or blood in the long term. Prostate cancer is the most common ...

Small fragments of plastic were found in nine out of 10 patients with prostate cancer, and in higher levels inside tumors than in nearby noncancerous tissue, a new study finds.

A prostate cancer patient in Gibraltar has been operated on remotely by a surgeon in London. On Wednesday, Prof Prokar ...

The methods of diagnosing and treating localised prostate cancer has changed significantly in the last two decades.

Robert F. Kennedy Jr. and his subordinates want Americans to have more conversations with their physicians. But they also can ...

Inside UK’s first remote robotic surgery as surgeon operates on prostate cancer patient 2,400km away - A surgeon in London performed the operation on Paul Buxton, a 62-year-old based in Gibraltar ...

Salvage focal therapy and radical prostatectomy are both effective in treating localized radiorecurrent prostate cancer, a cohort study suggested. There were no statistically significant differences ...

King Faisal Specialist Hospital and Research Centre (KFSH) in Riyadh has successfully introduced a pioneering high-intensity focused ultrasound (HIFU) treatment for prostate cancer for the first time ...

This summary report is based on the NICE assumptions used in the resource impact template. Users can amend the 'Population and treatments' and 'Unit costs' worksheets in the template to reflect local ...

MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment, today announced the U.S.